Zhejiang Tailin BioEngineering Co.,Ltd
SHZ: 300813.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Da Lin Ye
- Employees
- 888
- Headquarters
- Hangzhou, China
- IPO year
- 2020
- Market cap
- CN¥3.1B
- Website
- https://www.tailingood.com
Loading 300813…
Loading profile data…Frequently asked questions about 300813
What does Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ) do?
Zhejiang Tailin BioEngineering Co.,Ltd manufactures microbial test and control equipment, mainly for pharmaceutical and medical sector. The company offers sterility testing equipment, microbiological testing equipment, TOC analyzers, sterile isolation systems, hydrogen peroxide sterilization systems, sterile delivery system, and filters, as well...
Where does 300813.SZ trade?
Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300813.SZ in?
Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Zhejiang Tailin BioEngineering Co.,Ltd?
Da Lin Ye is the chief executive officer of Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ).
Where is Zhejiang Tailin BioEngineering Co.,Ltd headquartered?
Zhejiang Tailin BioEngineering Co.,Ltd is headquartered in China.
Does 300813.SZ pay a dividend?
Yes — Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ) paid a trailing twelve-month dividend of CNY 0.23 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300813.SZ go public?
Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ) completed its initial public offering in 2020.